RU2697251C2 - Способы получения 1, 3-бензодиоксольных гетероциклических соединений - Google Patents

Способы получения 1, 3-бензодиоксольных гетероциклических соединений Download PDF

Info

Publication number
RU2697251C2
RU2697251C2 RU2017101808A RU2017101808A RU2697251C2 RU 2697251 C2 RU2697251 C2 RU 2697251C2 RU 2017101808 A RU2017101808 A RU 2017101808A RU 2017101808 A RU2017101808 A RU 2017101808A RU 2697251 C2 RU2697251 C2 RU 2697251C2
Authority
RU
Russia
Prior art keywords
compound
formula
defined above
carried out
chlorine
Prior art date
Application number
RU2017101808A
Other languages
English (en)
Russian (ru)
Other versions
RU2017101808A3 (enExample
RU2017101808A (ru
Inventor
Бьерн МЕТЦЛЕР
Андре ФАЛЬДТ
Original Assignee
Лео Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фарма А/С filed Critical Лео Фарма А/С
Publication of RU2017101808A publication Critical patent/RU2017101808A/ru
Publication of RU2017101808A3 publication Critical patent/RU2017101808A3/ru
Application granted granted Critical
Publication of RU2697251C2 publication Critical patent/RU2697251C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2017101808A 2014-06-23 2015-06-22 Способы получения 1, 3-бензодиоксольных гетероциклических соединений RU2697251C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397 2014-06-23
EP14173397.2 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (3)

Publication Number Publication Date
RU2017101808A RU2017101808A (ru) 2018-07-27
RU2017101808A3 RU2017101808A3 (enExample) 2019-01-22
RU2697251C2 true RU2697251C2 (ru) 2019-08-13

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017101808A RU2697251C2 (ru) 2014-06-23 2015-06-22 Способы получения 1, 3-бензодиоксольных гетероциклических соединений

Country Status (18)

Country Link
US (1) US9908894B2 (enExample)
EP (1) EP3157930B1 (enExample)
JP (1) JP6785666B2 (enExample)
KR (1) KR20170016894A (enExample)
CN (1) CN106459081B (enExample)
AU (1) AU2015279428B2 (enExample)
BR (1) BR112016029510A2 (enExample)
CA (1) CA2953284A1 (enExample)
DK (1) DK3157930T3 (enExample)
ES (1) ES2702451T3 (enExample)
IL (1) IL249336A0 (enExample)
MX (1) MX2016016378A (enExample)
PL (1) PL3157930T3 (enExample)
PT (1) PT3157930T (enExample)
RU (1) RU2697251C2 (enExample)
TW (1) TW201613934A (enExample)
WO (1) WO2015197534A2 (enExample)
ZA (1) ZA201608442B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3390407T3 (da) 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
AU2018286964B2 (en) 2017-06-20 2022-04-14 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2019115776A1 (en) 2017-12-15 2019-06-20 Leo Pharma A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
KR20210117300A (ko) 2019-01-15 2021-09-28 유니온 테라퓨틱스 에이/에스 포스포디에스테라제 억제제를 함유하는 변형 방출 정제 제형
KR20230159485A (ko) 2021-03-22 2023-11-21 유니온 테라퓨틱스 에이/에스 오리스밀라스트를 사용한 화농땀샘염의 치료
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996036624A1 (en) * 1995-05-19 1996-11-21 Kyowa Hakko Kogyo Co., Ltd. Oxygen-containing heterocyclic compounds
WO2011160632A1 (en) * 2010-06-24 2011-12-29 Leo Pharma A/S Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
RU2495043C2 (ru) * 2007-02-28 2013-10-10 Лео Фарма А/С Новые ингибиторы фосфодиэстераз

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
AU2003252467A1 (en) * 2002-07-03 2004-01-23 Kyowa Hakko Kogyo Co., Ltd. Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
DE602007012105D1 (de) * 2006-07-14 2011-03-03 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
US8148537B2 (en) 2006-12-22 2012-04-03 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
ZA200905371B (en) * 2007-02-28 2010-10-27 Leo Pharma As Novel phosphodiesterase Inhibitors
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
DK3390407T3 (da) * 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996036624A1 (en) * 1995-05-19 1996-11-21 Kyowa Hakko Kogyo Co., Ltd. Oxygen-containing heterocyclic compounds
RU2495043C2 (ru) * 2007-02-28 2013-10-10 Лео Фарма А/С Новые ингибиторы фосфодиэстераз
WO2011160632A1 (en) * 2010-06-24 2011-12-29 Leo Pharma A/S Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors

Also Published As

Publication number Publication date
CN106459081B (zh) 2019-09-10
AU2015279428B2 (en) 2018-02-15
US20170137438A1 (en) 2017-05-18
WO2015197534A3 (en) 2016-03-17
ES2702451T3 (es) 2019-03-01
PT3157930T (pt) 2018-12-24
IL249336A0 (en) 2017-02-28
EP3157930B1 (en) 2018-10-17
ZA201608442B (en) 2018-05-30
TW201613934A (en) 2016-04-16
RU2017101808A3 (enExample) 2019-01-22
JP6785666B2 (ja) 2020-11-18
CA2953284A1 (en) 2015-12-30
JP2017520547A (ja) 2017-07-27
DK3157930T3 (en) 2019-01-21
WO2015197534A2 (en) 2015-12-30
EP3157930A2 (en) 2017-04-26
MX2016016378A (es) 2017-10-16
US9908894B2 (en) 2018-03-06
RU2017101808A (ru) 2018-07-27
BR112016029510A2 (pt) 2017-08-22
PL3157930T3 (pl) 2019-04-30
KR20170016894A (ko) 2017-02-14
CN106459081A (zh) 2017-02-22
AU2015279428A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
JP7549635B2 (ja) 1,3-ベンゾジオキソール複素環式化合物の調製方法
EP3157930B1 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
JP6934872B2 (ja) 1,3−ベンゾジオキソール複素環化合物の製造方法
KR102627711B1 (ko) 벤즈옥사졸 화합물의 제조 방법
RU2814175C2 (ru) Способы получения 1,3-бензодиоксольных гетероциклических соединений
HK1231056A1 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
HK40029630B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2010127574A1 (zh) 对称的1,10-菲络啉衍生物的一步合成方法
JPH06184104A (ja) N−アリールマレイミド類の製造方法
BR112018011589B1 (pt) Método para preparar um composto, e, composto

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20211019